Actively Recruiting

Phase 4
Age: 18Years - 80Years
All Genders
NCT04935021

Clinical Study of ATTR-CM

Led by Second Affiliated Hospital, School of Medicine, Zhejiang University · Updated on 2023-01-31

100

Participants Needed

1

Research Sites

521 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

In this study, patients with ATTR-CM or gene carriers were selected to study the diagnosis and treatment, and long-term follow-up was conducted.

CONDITIONS

Official Title

Clinical Study of ATTR-CM

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients and gene carriers of ATTR-CM confirmed in the Second Affiliated Hospital of Zhejiang University School of Medicine
  • Age between 18 and 90 years
  • Ability to understand the study and cooperate with investigators
Not Eligible

You will not qualify if you...

  • Unable to understand or unwilling to fill in informed consent forms or attend follow-up visits

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

xiaohong University PAN

Hangzhou, Zhejiang, China

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here